Activity of 18 antimicrobial agents against multi-resistant strains of Staphylococcus aureus isolated from intensive care patients

Infection ◽  
1985 ◽  
Vol 13 (5) ◽  
pp. 240-242 ◽  
Author(s):  
D. Duncker ◽  
U. Ullmann
2021 ◽  
Author(s):  
Melissa R. Gitman ◽  
Bremy Alburquerque ◽  
Adriana van de Guchte ◽  
Mitchell J. Sullivan ◽  
Ajay Obla ◽  
...  

AbstractActive surveillance in our neonatal intensive care unit identified Staphylococcus aureus cultures from two infants with heterogeneity in methicillin resistance between isolated subclones lacking mecA and mecC. Whole-genome analysis of 4 modified (MODSA) and 4 methicillin-susceptible (MSSA) subclones for each culture identified either truncating mutations in the cyclic diadenosine monophosphate phosphodiesterase enzyme (GdpP), or a nonsynonymous substitution in penicillin binding protein 2 (PBP2). These cases highlight the difficulty in identifying non-mecA/non-mecC-mediated methicillin-resistance in clinical laboratories.


Author(s):  
Leila Akhtar Danesh ◽  
Zeinab Saiedi Nejad ◽  
Hossein Sarmadian ◽  
Saeed Fooladvand ◽  
Alex van Belkum ◽  
...  

2005 ◽  
Vol 49 (9) ◽  
pp. 3690-3696 ◽  
Author(s):  
Michelle L. Embleton ◽  
Sean P. Nair ◽  
Wendy Heywood ◽  
Dev C. Menon ◽  
Barry D. Cookson ◽  
...  

ABSTRACT Light-activated antimicrobial agents (photosensitizers) are promising alternatives to antibiotics for the treatment of topical infections. To improve efficacy and avoid possible damage to host tissues, targeting of the photosensitizer to the infecting organism is desirable, and this has previously been achieved using antibodies and chemical modification of the agent. In this study we investigated the possibility of using a bacteriophage to deliver the photosensitizer tin(IV) chlorin e6 (SnCe6) to Staphylococcus aureus. SnCe6 was covalently linked to S. aureus bacteriophage 75, and the ability of the conjugate to kill various strains of S. aureus when exposed to red light was determined. Substantial kills of methicillin- and vancomycin-intermediate strains of S. aureus were achieved using low concentrations of the conjugate (containing 1.5 μg/ml SnCe6) and low light doses (21 J/cm2). Under these conditions, the viability of human epithelial cells (in the absence of bacteria) was largely unaffected. On a molar equivalent basis, the conjugate was a more effective bactericide than the unconjugated SnCe6, and killing was not growth phase dependent. The conjugate was effective against vancomycin-intermediate strains of S. aureus even after growth in vancomycin. The results of this study have demonstrated that a bacteriophage can be used to deliver a photosensitizer to a target organism, resulting in enhanced and selective killing of the organism. Such attributes are desirable in an agent to be used in the photodynamic therapy of infectious diseases.


2005 ◽  
Vol 24 (9) ◽  
pp. e1
Author(s):  
Lisa A. Grohskopf ◽  
W Charles Huskins ◽  
Ronda L. Sinkowitz-Cochran ◽  
Gail L. Levine ◽  
Donald A. Goldmann ◽  
...  

2020 ◽  
Vol 41 (11) ◽  
pp. 1181-1186
Author(s):  
Mohamed Ali ◽  
Ahmad Rajab ◽  
Abdullah Al-Khani ◽  
Saleh Ayash ◽  
Amjad Chamsi Basha ◽  
...  

2005 ◽  
Vol 24 (9) ◽  
pp. 766-773 ◽  
Author(s):  
Lisa A. Grohskopf ◽  
W Charles Huskins ◽  
Ronda L. Sinkowitz-Cochran ◽  
Gail L. Levine ◽  
Donald A. Goldmann ◽  
...  

1980 ◽  
Vol 1 (2) ◽  
pp. 81-89 ◽  
Author(s):  
George Saroglou ◽  
Margaret Cromer ◽  
Alan L. Bisno

AbstractA methicillin-resistant strain of Staphylococcus aureus (MRSA, phage type 84/85) was introduced into City of Memphis Hospital by a burn patient who had recently been treated for MRSA bacteremia in another institution 500 miles distant. Despite prompt recognition of the problem and institution of isolation procedures, six other patients developed secondary colonization during the ensuing six months, and five of these experienced clinically significant infections with MRSA. Three of the patients originally infected with MRSA, as well as two additional patients, subsequently developed colonization with staphylococcal strains of phage type 84/85 that were resistant to both methicillin and gentamicin (MRGRSA). Spread of the staphylococcal strains was most likely accomplished primarily via passive transfer from person to person. The hydrotherapy unit, which became contaminated with both MRSA and MRGRSA, may have played a secondary role. As illustrated by this outbreak, patients carrying potentially dangerous bacterial strains should be identified and informed of the problems posed by such carriage. It may be imprudent to admit such patients to hospitals that are free of the potential pathogen.The outbreak described here exemplifies a number of potential problems associated with control of nosocomial staphylococcal infections: (a) interhospital spread of methicillin-resistant strains; (b) secondary patient-to-patient intrahospital spread; and (c) emergence of even more resistant strains, possibly associated with selective pressures exerted by widespread use of broad-spectrum antimicrobial agents.


2021 ◽  
Author(s):  
Riya Mukherjee ◽  
Anjali Priyadarshini ◽  
Ramendra Pati Pandey ◽  
Vethakkani Samuel Raj

Staphylococcus aureus is a Gram-Positive bacteria that are responsible to cause skin infections and also shows toxic shock syndrome. Several antibiotics were given against the S. aureus infections but eventually, the prevalence of multidrug resistance of Staphylococcus aureus started emerging. Since then Methicillin-resistant Staphylococcus aureus strains (MRSA)were very common which causes nosocomial infections. Microorganisms for the need of the survival undergoes mutational changes either in their chromosomal DNA/RNA which confers the resistance. One of the famous examples is the resistance against methicillin in Staphylococcus aureus. The evolution of S. aureus is successful in developing multiple resistant strains. Plasmids are capable of carrying the resistant genes and also several toxic genes. In a recent study, it has been observed that drug resistance genes are located in the R plasmids and they are also responsible in conferring multi drug resistance and induce less utilization of multiple antimicrobial therapy. MRSA was not only resistant to methicillin, studies proved MRSA strains were resistant to macrolides, tetracyclines, chloramphenicol. Resistance to vancomycin was very evidently observed, and its transfer among the population and rising of resistant strains was becoming a major threat globally. The resistance of all these antimicrobial agents against the pathogenic microorganisms are taking a rise in some patients due to prolong use of the antimicrobial agents by these patients. The multi drug resistance has enhanced the mortality and morbidity rate which referred to the infecting agents as the “Super Bugs”. Survival of the microorganisms has increased due to the gradual development of extensive resistance against varied antimicrobial drugs. Possible treatments with combinations are found to be the only hope for infections against S. aureus. Few drugs are in development such as Dalbavancin, Oritavancin, Tigecycline. These are the possible treatments upon which the work is going on to reduce the resistance against the invasive MRSA. This chapter highlights the profiles of Staphylococcus aureus and the resistance patterns along with transmission and the role of the plasmid in transmitting the resistance.


Sign in / Sign up

Export Citation Format

Share Document